SEC 13F Intelligence

Front Row Advisors LLC / AMGN

Front Row Advisors LLC’s Amgen Inc Position

Does Front Row Advisors LLC own Amgen Inc (AMGN)? Yes8.9K shares worth $3M (+1.07% of its 13F portfolio) as of Q1 2026, up from 8.9K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
8.9K
% of Portfolio
+1.07%
Quarters Held
29
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ1 ’22: $2MQ1 ’22Q2 ’22: $2MQ3 ’22: $2MQ4 ’22: $2,590Q1 ’23: $2,320Q1 ’23Q2 ’23: $2,132Q3 ’23: $3MQ4 ’23: $3MQ1 ’24: $3MQ1 ’24Q2 ’24: $3MQ3 ’24: $3MQ4 ’24: $2MQ1 ’25: $3MQ1 ’25Q2 ’25: $3MQ3 ’25: $3MQ4 ’25: $3MQ1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20268.9K$3M+1.07%
Q4 20258.9K$3M+0.97%
Q3 20259.0K$3M+0.85%
Q2 20259.0K$3M+0.88%
Q1 20259.0K$3M+1.08%
Q4 20249.3K$2M+0.83%
Q3 20249.3K$3M+1.07%
Q2 20249.4K$3M+1.02%
Q1 20249.4K$3M+0.99%
Q4 20239.3K$3M+1.23%
Q3 20239.4K$3M+1.17%
Q2 20239.6K$2,132+0.95%
Q1 20239.6K$2,320+1.11%
Q4 20229.9K$2,590+1.34%
Q3 202210.0K$2M+1.17%
Q2 202210.0K$2M+1.20%
Q1 202210.0K$2M+0.98%
Q3 20219.4K$2M+0.85%
Q2 20219.5K$2M+0.87%
Q1 20219.4K$2M+1.14%
Q4 20209.3K$2M+1.09%
Q3 20209.4K$2M+1.12%
Q2 20209.5K$2M+1.40%
Q1 20209.6K$2M+1.56%
Q4 20199.3K$2M+1.46%
Q3 20199.5K$2M+1.30%
Q2 20199.7K$2M+1.30%
Q1 20199.8K$2M+1.45%
Q4 201810.2K$2M+1.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Front Row Advisors LLC’s full portfolio or all institutional holders of AMGN.